Gynaecomastia in teenagers: when to wait, when to investigate and when to operate

The short answer reassures almost every family: pubertal gynaecomastia resolves spontaneously in 85-90% of cases, between six months and two years. Persisting beyond 17 is uncommon. That is why, faced with a new case in a boy of 13 or 14, what is indicated almost always is waiting with follow-up, not surgery.

Waiting, however, does not mean washing your hands of it. It means two specific things: first ruling out another cause behind it and setting a deadline rather than leaving it open-ended. And it also means recognising that there are cases in which waiting stops making sense, because the tissue is no longer going to regress and the boy has spent years organising his life around a T-shirt.

This page sets out, for adolescence, the general criterion of the general guide to gynaecomastia.

How many teenagers really have it

The figures that circulate are bewildering because they measure different things. A population study of 531,686 boys aged 12 to 15 found a diagnosed incidence of 1.08%, falling to 0.7% among those with a normal body mass index, with 70% of the cases concentrated between the ages of 13 and 14.

That figure sits alongside the much higher prevalences obtained by examining every teenager in a sample. And the difference is informative in itself: feeling some glandular tissue on examination is one thing and having gynaecomastia that gets as far as being brought to a doctor and diagnosed is another. Most of the former never becomes the latter.

For a family, what is useful about these numbers is that they place the case: appearing at 13 or 14 is what should be expected, and it is not an oddity calling for an explanation.

The window in which it resolves on its own

The mechanism is development itself. During puberty there is a transient imbalance between oestrogenic and androgenic activity, and that imbalance stimulates breast tissue. As androgen production becomes established, the stimulus disappears and the tissue regresses.

The timings we work with are the ones that have been described: most resolve between six months and two years. Up-to-date reviews on gynaecomastia in adolescents describe it as a transient condition, with resolution that can take anything from several months to a few years.

Why in time it stops resolving

This is the part almost never explained at home, and it is what gives waiting a limit.

The tissue of a recent gynaecomastia is active: ducts and stroma proliferating in response to a hormonal stimulus. If the stimulus ceases, that tissue can regress. Over the months, however, it is gradually replaced by fibrous tissue, and fibrous tissue no longer responds to anything: it does not regress even if the hormones return to normal.

That change can even be seen on imaging. Reviews of imaging in gynaecomastia describe a nodular pattern in recent forms and a dendritic pattern in persistent, already fibrotic ones; on ultrasound, the lesion becomes more echogenic as the fibrosis sets in.

Translated: waiting makes sense inside the window, and stops making sense outside it.

What has to be ruled out before deciding to wait

Waiting is a clinical decision, and as such it is taken after looking, not before. The assessment recommended by the European guidelines includes:

• History: when it appeared, whether it has changed, whether it hurts, and —very important at this age— medication and substances, including supplements and gym products.
• Examination of the breast and of the genitals, to confirm that there is glandular tissue and to check that pubertal development is where it should be.
• Blood tests and further investigations when something does not fit: gynaecomastia that appears before puberty begins, that grows quickly, that is very bulky or that comes with abnormal pubertal development is not the typical pubertal kind and deserves investigation.

And the signs that do not wait: a lump that is hard, on one side only, off-centre from the areola or fixed, or any change in the skin or the nipple.

Waiting properly: what it means in practice

• A deadline, not a “we’ll see”. A review is set —usually at six months— and a comparison is made.
• No hormonal treatments on your own initiative. The European guidelines do not generally justify the use of oestrogen receptor modulators or aromatase inhibitors to treat gynaecomastia, and in a teenager the risk of self-medicating with whatever is recommended at the gym is more than theoretical.
• Mind the weight, yes, but without false promises. Losing weight reduces the fatty component and helps; it does nothing to the glandular disc, and it is worth telling the boy so that he does not read as his own failure something that was never up to him.
• Do not play down the impact. A boy who avoids the swimming pool, the changing room or taking his T-shirt off in summer is paying a real price while everyone waits, and that forms part of the assessment.

When surgery is considered

When these conditions are met at the same time:

• the gynaecomastia persists beyond the window —typically more than two years, or beyond the age of 17 or 18—;
• pubertal development is complete;
• an underlying cause has been ruled out or treated;
• and there is a real impact, physical or psychological, that justifies intervening.

What is not a criterion: haste, the summer, or size on its own.

What the evidence says about operating on a teenager

Here there is good data, and it is worth knowing because the debate has been open for years.

A longitudinal study compared 44 teenagers operated on for gynaecomastia with 64 boys without it, aged 12 to 21, using validated questionnaires on self-esteem and quality of life. Before surgery, the boys with gynaecomastia scored significantly worse than the controls on self-esteem and on five quality-of-life domains —general health, vitality, social functioning, emotional role and mental health. After surgery they improved significantly and, above all, came to score comparably to the boys without gynaecomastia across every domain measured.

Two conclusions from that piece of work deserve quoting as they stand:

• the improvement was greater in the younger patients, in those who were overweight or obese and in moderate or severe cases;
• age and body mass index, on their own, should not contraindicate surgery.

A second piece of work, on 145 patients aged 12 to 21, confirms the improvement in self-esteem and in seven quality-of-life domains, and offers the other side with the same honesty: 36% of the breasts had some complication over a median of 8.6 months of follow-up, mainly residual tissue and contour irregularities. Both things are true at once, and a family deserves to know both before deciding.

Talking about it at home

This is not a sentimental section: how it is put changes the decision.

• Let the boy ask for the consultation, not just the parents. Operating on someone who has not asked for it rarely turns out well.
• Separate “I have it” from “something is wrong with me”. Knowing that it happens to most teenagers and that it almost always goes away reduces the distress enormously.
• Put waiting with a date first. “We’ll look at it in six months” is an answer; “it’ll go away” is not.
• Do not promise a result. Not even when the indication is perfectly clear.

Frequently asked questions

Will it go away on its own?

In 85-90% of cases, yes: pubertal gynaecomastia resolves spontaneously between six months and two years. Persisting beyond 17 is uncommon. That is why what is indicated in a new case is usually to assess and wait with follow-up.

Is there a minimum age for surgery?

There is no magic number, but the criterion is that pubertal development should be complete and that the gynaecomastia should have persisted beyond its natural window. Operating earlier means intervening on something that was probably going to disappear on its own.

Is it better to wait until he has finished growing even if he is having a bad time?

It is the difficult question, and the answer is not automatic. The general criterion is to wait inside the window; but the psychological impact forms part of the assessment, and there is evidence that the improvement in quality of life is greatest precisely in the younger patients. It is decided case by case, in consultation and with the boy present.

Can he be given tablets to make it go away?

The European guidelines do not generally justify the use of oestrogen receptor modulators or aromatase inhibitors to treat gynaecomastia. What does matter is ruling out a treatable cause, which is another matter.

Could it be something serious?

It is uncommon, but it is precisely what is ruled out at the first assessment. What causes concern is a hard lump, on one side only, off-centre from the areola or fixed; gynaecomastia that appears before puberty begins; or pubertal development that does not fit.

Does weight matter?

Yes, on the fatty component. Losing weight reduces that part and helps, but it does nothing to the glandular tissue. It is worth explaining to the boy so that he does not experience as his own failure something that was never down to his effort.

If he does end up having surgery, will he have a scar?

In the usual plan, an incision at the lower edge of the areola, camouflaged in the change of skin colour, plus two very small access points. Only when there is a lot of excess skin are additional scars considered, and that is explained before surgery.

Sources

• Nuzzi LC, Firriolo JM, Pike CM, Cerrato FE, DiVasta AD, Labow BI. The Effect of Surgical Treatment for Gynecomastia on Quality of Life in Adolescents. J Adolesc Health. 2018;63(6):759-765. PMID 30279103 — 44 teenagers operated on against 64 healthy controls: worse baseline scores on self-esteem and five quality-of-life domains, significant improvement after surgery and scores comparable to those of the controls across every domain; the improvement was greater in the younger boys, in those who were overweight or obese and in moderate or severe cases, and the authors conclude that age and body mass index on their own should not contraindicate surgery.
• McNamara CT, Nuzzi LC, Firriolo JM, et al. Complications and Quality of Life following Gynecomastia Correction in Adolescents and Young Men. Plast Reconstr Surg. 2022;149(6):1062e-1070e. PMID 35349529 — 145 patients aged 12 to 21: significant improvement in self-esteem and in seven quality-of-life domains, and complications in 36% of the breasts over a median of 8.6 months, mainly residual tissue and contour irregularities.
• Berger O, Hornik-Lurie T, Talisman R. Pubertal gynecomastia incidence among 530,000 boys: a cross sectional population based study. Front Pediatr. 2024;12:1367550. PMID 38510076 — 531,686 boys aged 12 to 15: a diagnosed incidence of 1.08%, of 0.7% among those with a normal body mass index, with 70% of the cases between the ages of 13 and 14.
• Metwalley KA, Farghaly HS. Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment. Ann Pediatr Endocrinol Metab. 2024;29(2):75-81. PMID 38712491 — pubertal gynaecomastia as the main cause in adolescence, due to an imbalance between oestrogenic and androgenic activity, transient in character and with resolution that can take from months to years.
• Billa E, Kanakis GA, Goulis DG. Imaging in gynecomastia. Andrology. 2021;9(5):1444-1456. PMID 34033252 — a nodular pattern in recent forms and a dendritic one in persistent, already fibrotic ones; on ultrasound the lesion becomes more echogenic as the fibrosis sets in.
• Kanakis GA, Nordkap L, Bang AK, et al. EAA clinical practice guidelines—gynecomastia evaluation and management. Andrology. 2019;7(6):778-793. PMID 31099174 — the content of the assessment —history, examination of breast and genitals, blood tests where appropriate—, watchful waiting and the absence of general justification for oestrogen receptor modulators and aromatase inhibitors.

Sources checked one by one against PubMed on 12 August 2026.

Book your consultation

If your son has breast tissue and you are not sure whether to wait or to seek advice, what settles the question is an assessment: confirming that it is pubertal gynaecomastia, ruling out other causes and leaving the consulting room with a specific deadline instead of uncertainty. At the Instituto de Cirugía Plástica del Mediterráneo, in Valencia, in most of these cases the recommendation is to wait with follow-up, and that is what is said.

—

Clinical confirmation by the surgeon

Awaiting signature.

Educational content reviewed by Dr Alessandro Thione, registration no. 46/4621959, and Dr Alberto Ruiz Cases, registration no. 46/4624050, specialists in Plastic, Aesthetic and Reconstructive Surgery. Assessing gynaecomastia in a minor requires an examination in person; this information does not replace a medical consultation.

Dr Alessandro Thione

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4621959

Dr Alberto Ruiz Cases

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4624050

Last reviewed: 6 September 2026. This content is for information only and does not replace an individual assessment by a healthcare professional.